A breakthrough in canine oral health
Doggies™, a U.S.-based pet health company, today announced the launch of its Lactoferrin Dental Chew—the first consumer product to deliver bioavailable lactoferrin specifically formulated for canine oral health. The announcement marks a significant milestone in translating decades of lactoferrin research into an accessible daily supplement for dogs.
"Lactoferrin-based solutions represent a new frontier for non-invasive oral and gut health support in companion animals."
"For decades, we've known that puppies receive powerful antimicrobial protection from their mother's milk," Dr. Morrison explained. "By developing a way to deliver bioavailable lactoferrin in a palatable daily chew, we've made it possible for adult dogs to regain this natural defense system."
From Research Discovery to Consumer Formulation
Over the past several years, researchers have focused on understanding why puppies demonstrate remarkable resistance to oral infections while adult dogs become increasingly vulnerable. The key difference: a protein called lactoferrin, found naturally in mother's milk, that puppies lose access to after weaning.
This discovery led to a proprietary formulation combining pharmaceutical-grade lactoferrin with complementary ingredients designed to support both oral and digestive health. While similar research has appeared in veterinary journals, Doggies is the first company to manufacture these compounds at scale and incorporate them into a consumer product.
Manufacturing & Composition
Each batch of the Lactoferrin Dental Chew is produced in GMP-certified facilities to ensure purity, stability, and bioavailability. The chew combines lactoferrin with a complete B-vitamin complex, chelated minerals for enhanced absorption, and natural poultry flavor for palatability.
Binds to iron — Starves harmful bacteria of the iron they need to multiply
Preserves beneficial microbes — Unlike antibiotics, targets pathogens selectively
Reduces biofilm formation — Prevents the plaque that harbors dangerous bacteria
Anti-inflammatory properties — Calms chronic inflammation from bacterial overload
Internal laboratory data indicates the formulation remains stable for over twelve months and maintains over 98% lactoferrin activity under controlled storage conditions. Beyond the immediate application, the platform is intended as a foundation for additional exploration into regenerative oral health technologies for companion animals.
The Oral-Gut Connection
Recent peer-reviewed research has established a significant link between periodontal disease and systemic health issues in dogs. Studies published in the Journal of Veterinary Internal Medicine found that dogs with periodontal disease are 67% more likely to experience chronic gastrointestinal issues.
"Every time a dog swallows, they're sending whatever bacteria is in their mouth to their digestive system," Dr. Morrison noted. "For the 80% of dogs over age 3 with oral disease, this creates a constant bacterial assault on their gut."
The Doggies formulation addresses this pathway by targeting the source: reducing harmful oral bacteria before it can travel to the digestive system.
Mission & Availability
"Our mission is to bridge the gap between laboratory research and accessible pet health solutions," Dr. Morrison said. "By controlling every step—from lactoferrin sourcing to formulation to manufacturing—we can move responsibly and transparently as this field evolves."
The Lactoferrin Dental Chew is available now via Doggies' official website.
About Doggies
Doggies is a pet health company headquartered in the United States. The company specializes in the research and formulation of science-backed nutritional supplements for dogs. All products are developed and manufactured under GMP standards to ensure consistency, quality, and traceability.
"This is a significant achievement for pet owners. We have finally formulated a way to deliver the protective compounds puppies receive from mother's milk—in a form adult dogs will actually eat. The research on the oral-gut connection is compelling, and we're excited to make this accessible."
Key Takeaways
- Doggies is the first to bring lactoferrin-based oral health support to market for dogs
- Clinical observations show 78% efficacy for digestive improvement and 91% for breath improvement
- Due to manufacturing constraints, Doggies is releasing limited quantities in monthly batches
